Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02560051
Title Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications

prostate adenocarcinoma

Therapies

Degarelix

Aldoxorubicin + Docetaxel + Estramustine + Ketoconazole

Age Groups: adult
Covered Countries USA


No variant requirements are available.